Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants

Is glutamine depletion needed in ALL disease?

(2014) V. I. Avramis   BLOOD

Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine

(2013) E. A. Ehsanipour et al.   CANCER RESEARCH

Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity

(2010) M. N. Offman et al.   BLOOD

Targeting glia for treatment of neurological disease

(2010) David A. Rempe et al.   Neurotherapeutics

Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase

(2010) Claudia Scotti et al.   PLoS One

Structure ofHelicobacter pyloriL-asparaginase at 1.4 Å resolution

(2009) Prathusha Dhavala et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

The Human Asparaginase-like Protein 1 hASRGL1 Is an Ntn Hydrolase with β-Aspartyl Peptidase Activity

(2009) Jason R. Cantor et al.   BIOCHEMISTRY

Helicobacter pyloril-asparaginase: A promising chemotherapeutic agent

(2008) Donata Cappelletti et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS